Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05855343 · ClinicalTrials.gov registry record · NA
Exploratory Study of Switching From Combustible Cigarettes to the BIDI E-cigarette
A NA study, sponsored by Rose Research Center.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT05855343: Completed NA study, sponsored by Rose Research Center.
NCT05855343 is a NA study that has completed, run by Rose Research Center. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05855343, a NA study, has completed, sponsored by Rose Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The aim of this study is to shed light on the importance of nicotine pharmacokinetics in switching to a reduced-harm product by fully matching the nicotine pharmacokinetics of smokers' usual brands of cigarettes. The primary objective is to ascertain the degree of smoking reduction when smokers attempt to switch to an e-cigarette that matches peak nicotine concentrations of a cigarette.
Primary Outcome
Change in expired air carbon monoxide (CO) at the end of the product use period
Interventions
- OTHER BIDI Stick e-cigarette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2023-02-14 |
| Est. Completion | 2023-12-05 |
| Phase | NA |
What the finished NCT05855343 record still lists
NCT05855343 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which BIDI Stick e-cigarette is the first listed.
NCT05855343 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05855343 about?
NCT05855343 is a clinical study titled "Exploratory Study of Switching From Combustible Cigarettes to the BIDI E-cigarette". The aim of this study is to shed light on the importance of nicotine pharmacokinetics in switching to a reduced-harm product by fully matching the nicotine pharmacokinetics of smokers' usual brands of cigarettes. The primary objective is to ascertain the degree of smoking reduction when smokers att...
What is the current status of trial NCT05855343?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2023-02-14. Estimated completion is 2023-12-05.
What interventions are being tested in trial NCT05855343?
The interventions under investigation include: BIDI Stick e-cigarette (OTHER).
Who is sponsoring clinical trial NCT05855343?
This trial is sponsored by Rose Research Center, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05855343's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI